Retaglutide is a novel GLP-1 receptor agonist currently under investigation for the control of metabolic disorders. This therapy works by enhancing the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring https://jakubkmql041982.jts-blog.com/37727476/semaglutide-a-potential-solution-for-metabolic-disorders